AMINOPYRIMIDINE COMPOUNDS AS PLK INHIBITORS

The invention relates to aminopyrimidine compounds useful for treating diseases mediated by polo-like kinase 1 (Plk1). The invention also relates to the therapeutic use of such aminopyrimidine compounds and compositions thereof in treating disease states associated with abnormal cell growth and unwa...

Full description

Saved in:
Bibliographic Details
Main Authors LIU, GANG, PARAS, NICK, A, RETZ, DANIEL, MARTIN, RAINBEAU, ELIZABETH, BRENNAN, PAUL, EDWARD, SMITH, ADRIAN, LEONARD, DEMORIN, FRENEL, FILS
Format Patent
LanguageEnglish
French
German
Published 12.09.2007
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The invention relates to aminopyrimidine compounds useful for treating diseases mediated by polo-like kinase 1 (Plk1). The invention also relates to the therapeutic use of such aminopyrimidine compounds and compositions thereof in treating disease states associated with abnormal cell growth and unwanted cell proliferation.
Bibliography:Application Number: EP20050854551